We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Four Point Test Flags Patients at Risk of Dying from Clostridium difficile Infection

By LabMedica International staff writers
Posted on 20 Aug 2013
Analysis of metabolic and mortality data from a group of patients with Clostridium difficile infections has allowed the establishment of a prediction rule based on clinical variables to aid hospital physicians to rank incoming patients according to risk of dying from the infection.

C. More...
difficile is an anaerobic, spore forming, rod shaped bacterium, and is a prevalent cause of nosocomial infection. Furthermore, antibiotic resistant strains of C. difficile are a growing problem in healthcare systems. Recent C. difficile epidemics have been caused by hypervirulent strains, which became resistant to the fluoroquinolones soon after their introduction into the healthcare setting.

When C. difficile bacteria are introduced into a colon in which the normal gut flora has been destroyed (usually after a broad-spectrum antibiotic such as clindamycin has been used), the gut becomes overrun with C. difficile. This overpopulation is harmful because the bacteria release toxins that can cause bloating and diarrhea, with abdominal pain, which may become severe. C. difficile infections are the most common cause of pseudomembranous colitis, and in rare cases, this can progress to toxic megacolon, which can be life threatening.

Investigators at the University of Exeter (United Kingdom) and the Royal Devon & Exeter Hospital (United Kingdom) evaluated over 186 variables collated retrospectively from clinical data for 213 patients. From this data, they devised a simple four variable prediction rule that included serum albumin levels, respiratory rate, C-reactive protein, and white cell count. Threshold levels of these variables were associated with an increased risk of all-cause mortality.

Contributing author Dr. Steve Michell, senior lecturer in molecular microbiology at the University of Exeter, said, "Our findings are exciting because they identify a simple, accurate, and robust method to identify those patients who are at risk of dying from a C difficile infection. The clinical variables identified are easily measurable, using tests that are commonly carried out in hospital. The results of our study strengthen the evidence for establishing the use of this rule in clinical settings: the benefits to patient well-being, the efficient management of infection in hospital and potential savings to the NHS and other health services around the world, would be immense."

The study was published in the July 12, 2013, online edition of the journal BMC Infectious Diseases.

Related Links:
University of Exeter
Royal Devon & Exeter Hospital


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Gold Member
Collection and Transport System
PurSafe Plus®
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: Erythrocyte Sedimentation Rate Sample Stability (Photo courtesy of ALCOR Scientific)

ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours

Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.